Latest Press Release: 7th April 2015
Cambridge Biopharmaceutical Start-up Attracts £4m to Develop Next-Generation Screening Platform
Tuesday 7 April 2015 PhoreMost ( www.phoremost.com ), a Cambridge-based biopharmaceutical company, has raised £4m in an A round of equity and grant funding, of which the equity is led by Amadeus Capital Partners and Abcam founder, Jonathan Milner. Cambridge Enterprise and angels have also participated in the funding. There has been considerable progress [...]